These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 29952210)

  • 1. Brief report: Department of Defense midseason vaccine effectiveness estimates for the 2017-2018 influenza season.
    Shoubaki L; Eick-Cost AA; Hawksworth A; Hu Z; Lynch L; Myers CA; Federinko S
    MSMR; 2018 Jun; 25(6):26-28. PubMed ID: 29952210
    [No Abstract]   [Full Text] [Related]  

  • 2. Brief report: Department of Defense midseason estimates of vaccine effectiveness for the 2018-2019 influenza season.
    Lynch LC; Coleman R; DeMarcus L; Scheckelhoff M; Eick-Cost AA; Hu Z; Hansen CJ; Graf PCF; Myers CA; Federinko S; Johnson A
    MSMR; 2019 Jul; 26(7):24-27. PubMed ID: 31347373
    [No Abstract]   [Full Text] [Related]  

  • 3. Department of Defense end-of-season influenza vaccine effectiveness estimates for the 2017-2018 season.
    Coleman R; Eick-Cost AA; Hawksworth AW; Hu Z; Lynch L; Myers CA; DeMarcus L; Federinko S
    MSMR; 2018 Oct; 25(10):16-20. PubMed ID: 31066571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brief report: Department of Defense Global, Laboratory-based Influenza Surveillance Program's influenza vaccine effectiveness estimates and surveillance trends for 2016-2017 influenza season.
    Shoubaki LA
    MSMR; 2018 Jan; 25(1):8-9. PubMed ID: 29381077
    [No Abstract]   [Full Text] [Related]  

  • 5. Brief report: mid-season influenza vaccine effectiveness estimates for the 2013-2014 influenza season.
    Cost AA; Hiser MJ; Hu Z; Cooper MJ; Hawksworth AW; Radin JM; Brice GT; Zorich SC; DeMarcus LS; Tastad KJ; Sanchez JL
    MSMR; 2014 Jun; 21(6):15-7. PubMed ID: 24978474
    [No Abstract]   [Full Text] [Related]  

  • 6. Brief report: Mid-season influenza vaccine effectiveness estimates for the 2016-2017 influenza season.
    Toure E; Eick-Cost AA; Hawksworth AW; Cooper MJ; Hu Z; Myers CA; Kammerer PE; Ricketts MN; Federinko S
    MSMR; 2017 Aug; 24(8):17-19. PubMed ID: 28895750
    [No Abstract]   [Full Text] [Related]  

  • 7. Surveillance snapshot: Influenza vaccine effectiveness, U.S. European Command, as estimated by the Department of Defense Global, Laboratory-Based Influenza Surveillance Program, 2016-2017 influenza season.
    Shoubaki LA; DeMarcus L
    MSMR; 2017 Oct; 24(10):22. PubMed ID: 29077424
    [No Abstract]   [Full Text] [Related]  

  • 8. Influenza vaccination and respiratory virus interference among Department of Defense personnel during the 2017-2018 influenza season.
    Wolff GG
    Vaccine; 2020 Jan; 38(2):350-354. PubMed ID: 31607599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influenza vaccine effectiveness among US military basic trainees, 2005-06 season.
    Strickler JK; Hawksworth AW; Myers C; Irvine M; Ryan MA; Russell KL
    Emerg Infect Dis; 2007 Apr; 13(4):617-9. PubMed ID: 17553281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Live attenuated or inactivated influenza vaccines and medical encounters for respiratory illnesses among US military personnel.
    Wang Z; Tobler S; Roayaei J; Eick A
    JAMA; 2009 Mar; 301(9):945-53. PubMed ID: 19255113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surveillance snapshot: Influenza immunization among U.S. Armed Forces healthcare workers, August 2012-April 2017.
    Armed Forces Health Surveillance Branch
    MSMR; 2017 Oct; 24(10):23. PubMed ID: 29077425
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of the effectiveness of trivalent inactivated influenza vaccine and live, attenuated influenza vaccine in preventing influenza-like illness among US military service members, 2006-2009.
    Phillips CJ; Woolpert T; Sevick C; Faix D; Blair PJ; Crum-Cianflone NF
    Clin Infect Dis; 2013 Jan; 56(1):11-9. PubMed ID: 23183869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mid-season influenza vaccine effectiveness 2011-2012: a Department of Defense Global, Laboratory-based, Influenza Surveillance System case-control study estimate.
    MacIntosh VH; Tastad KJ; Eick-Cost AA
    Vaccine; 2013 Mar; 31(13):1651-5. PubMed ID: 23395733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mid-season influenza vaccine effectiveness for the 2012-2013 influenza season.
    Eick-Cost AA; Hu Z; Cooper MJ; Sanchez JL; Radin JM; Hawksworth AW; Brice GT; Lloyd LV; Tastad KJ; Zorich SC; MacIntosh VH
    MSMR; 2013 Mar; 20(3):15-6. PubMed ID: 23550929
    [No Abstract]   [Full Text] [Related]  

  • 15. Effectiveness of seasonal 2010/11 and pandemic influenza A(H1N1)2009 vaccines in preventing influenza infection in the United Kingdom: mid-season analysis 2010/11.
    Pebody R; Hardelid P; Fleming D; McMenamin J; Andrews N; Robertson C; Thomas D; Sebastianpillai P; Ellis J; Carman W; Wreghitt T; Zambon M; Watson J
    Euro Surveill; 2011 Feb; 16(6):. PubMed ID: 21329644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influenza vaccination of UK Armed Forces personnel, a waste of resources or an essential public health measure?
    Dermont M; Elmer T
    J R Army Med Corps; 2019 Dec; 165(6):390. PubMed ID: 30842222
    [No Abstract]   [Full Text] [Related]  

  • 17. Summary of the 2004-2005 influenza season in the U.S. Army Europe.
    Snyder A; Mancuso J; Aldous W
    Mil Med; 2006 Oct; 171(10):929-32. PubMed ID: 17076441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of the 2003-2004 influenza vaccine among U.S. military basic trainees: a year of suboptimal match between vaccine and circulating strain.
    Russell KL; Ryan MA; Hawksworth A; Freed NE; Irvine M; Daum LT;
    Vaccine; 2005 Mar; 23(16):1981-5. PubMed ID: 15734071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse events following pandemic influenza A (H1N1) 2009 monovalent and seasonal influenza vaccinations during the 2009-2010 season in the active component U.S. military and civilians aged 17-44years reported to the Vaccine Adverse Event Reporting System.
    Bardenheier BH; Duderstadt SK; Engler RJ; McNeil MM
    Vaccine; 2016 Aug; 34(37):4406-14. PubMed ID: 27449076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influenza vaccine effectiveness among 50-64-year-old persons during a season of poor antigenic match between vaccine and circulating influenza virus strains: Colorado, United States, 2003-2004.
    Herrera GA; Iwane MK; Cortese M; Brown C; Gershman K; Shupe A; Averhoff F; Chaves SS; Gargiullo P; Bridges CB
    Vaccine; 2007 Jan; 25(1):154-60. PubMed ID: 17064823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.